Yonhap News English on MSN47m
Celltrion gets U.S. FDA approval for new biosimilar for autoimmune disease treatmentSEOUL, Jan. 31 (Yonhap) -- Celltrion Inc., a major South Korean biopharmaceutical firm, said Friday its new biosimilar for an autoimmune disease treatment has received approval from the U.S. Food and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback